Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer

European Journal of Cancer

Volumn 36, Issue 2, 2000, Pages 235-241

  Bratt, O ^a   Damber, J E ^b   Emanuelsson, M ^b   Kristoffersson, U ^a   Lundgren, R ^a   Olsson, H ^b   Gronberg H ^b  

^a LUND UNIVERSITY   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

Attitudes; Genetics; Hereditary diseases; Prostatic neoplasms; Risk perception; Screening

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; CANCER SCREENING; DEPRESSION; FAMILIAL CANCER; GENETIC ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; QUESTIONNAIRE;

ADULT; AGED; ATTITUDE TO HEALTH; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; MALE; MIDDLE AGED; PEDIGREE; PROSTATIC NEOPLASMS; RISK FACTORS; SWEDEN;

EID: 0033965964     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(99)00272-5     Document Type: Article

References (36)

1. Eeles R, Ponder B, Easton D, Horwich A. Genetic Predisposition to Cancer. 1st edn. Oxford, Chapman & Hall, 1996.
2. Carter BS, Beaty TH, Steinberg GD, Childs B, Walsh PC. Mendelian inheritance of familial prostate cancer. Proc Nail Acad Sei USA 1992,89, 3367-3371.
3. Bratt O, KristofTersson U, Lundgren R, Olsson H. Familial and hereditary prostate cancer in southern Sweden. A populationbased case-control study. Eur J Cancer 1999, 35, 272-277.
4. Smith JR, Freije D, Carpten JD, et al. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genomewide search. Science 1996, 274, 1371-1374.
5. Xu J, Meyers D, Freije D, et al. Evidence for a prostate cancer susceptibility locus on the X chromosome. Nature Genetics 1998, 20, 175-179.
6. Berthon P, Valeri A, Cohen-Akenine A, et al. Predisposing gene for early-onset prostate cancer, located on chromosome Iq42.2-43. Am J Hum Genet 1998, 62, 1416-1424.
7. Lerman C, Rimer B, Engstrom P. Cancer risk notification: psychosocial and ethical implications. J Clin Oncol 1991, 9, 1275-1282.
8. Croyle R, Achilles J, Lerman C. Psychologic aspects of cancer genetic testing. A research update for clinicians. Cancer 1997, 80, 569-575.
9. Burke W, Daly M, Garber J, et al. Recommendations for followup care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. J Am Med Assoc 1997, 277, 997-1003.
10. Daly M, Lerman C, Ross E, Schwartz M, Burke Sands C, Masny A. Gail model breast cancer risk components are poor predictors of risk perception and screening behavior. Breast Cancer Res Treat 1996, 41, 59-70.
11. Evans DGR, Burnell LD, Hopwood P, Howell A. Perception of risk in women with a family history of breast cancer. Br J Cancer 1993,67, 612-614.
12. Gagnon P, Massie M, Kash K, et al. Perception of breast cancer risk and psychological distress in women attending a surveillance program. Psycho-Oncology 1996, 5, 259-269.
13. Julian-Reynier C, Eisinger F, Vennin P, et al. Attitudes towards cancer predictive testing and transmission of information to the family. J Med Genet 1996, 33, 731-736.
14. Kash KM, Holland JC, Halper MS, Miller DG. Psychological distress and surveillance behaviors of women with a family history of breast cancer. J Natl Cancer Inst 1992, 84, 24-30.
15. Lerman C, Daly M, Masny A, Balshem A. Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol 1994, 12, 843-850.
16. Lerman C, Daly S, Sands C, et al. Mammography adherence and psychological distress among women at risk for breast cancer. J Natl Cancer Inst 1993, 85, 1074-1080.
17. Lerman C, Hughes C, Lemon J, et al. What you don't know can hurt you: adverse psychologic effects in members of BRCA1linked and S.RC.42-linked families who decline genetic testing. J Clin Oncol 1998, 16, 1650-1654.
18. Lerman C, Seay J, Balshem A, Audrain J. Interest in genetic testing among first-degree relatives of breast cancer patients. Am J Med Genet 1995, 57, 385-392.
19. Lloyd S, Watson M, Waites B, et al. Familial breast cancer: a controlled study of risk perception, psychological morbidity and health beliefs in women attending for genetic counselling. Br J Cancer 1996, 74, 482-487.
20. McCaul K, O'Donnell S. Naive beliefs about breast cancer risk. Women's Health 1998, 4, 93-101.
21. Watson M, Duvivier V, Wade Walsh M, et al. Family history of breast cancer: what do women understand and recall about their genetic risk? J Med Genet 1998, 35, 731-738.
22. Lerman C, Kash K, Stefanek M. Younger women at increased risk of breast cancer: perceived risk, psychological well-being, and surveillance behaviour. Monogr Nail Cancer Inst 1994, 16, 171-176.
23. Lerman C, Lustbader E, Rimer B, et al. Effects of individualized breast cancer risk counseling: a randomized trial. J Nat! Cancer Inst 1995, 87, 286-292.
24. Struewing J, Lerman C, Kase R, Giambarresi T, Tucker M. Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiol Biomarkers Prev 1995,4, 169-173.
25. Bratt O, Kristoffersson U, Lundgren R, Olsson H. Sons of men with prostate cancer: their attitudes regarding possible inheritance of prostate cancer, screening, and genetic testing. Urology 1997, 50, 360-365.
26. Bratt O, Kristoffersson U, Lundgren R, Olsson H. The risk of malignant tumours in first-degree relatives of men with early onset prostate cancer: a population-based cohort study. Eur J Cancer 1997, 33, 2237-2240.
27. Grönberg H, Damber L, Damber J-E. Familial prostate cancer in Sweden, a nationwide register cohort study. Cancer 1996, 77, 138-143.
28. Horowitz M, Wilner N, Alvarez W. Impact of event scale: a measure of subjective stress. Psychosom Med 1979, 41, 209-218.
29. Zigmond A, Snaith R. The Hospital Anxiety and Depression Scale. Ada Psychiatr Scand 1983, 67, 361-370.
30. Grönberg H, Damber L, Damber J-E, Iselius L. Segregation analysis of prostate cancer in Sweden: support for dominant inheritance. Am J Epidemiol 1997, 146, 552-557.
31. Schaid D, McDonnel S, Blute M, Thibodeau S. Evidence for autosomal dominant inheritance of prostate cancer. Am J Hum Genet 1998, 62, 1425-1438.
32. Ward J, Hughes A, Hirst G, Winchester L. Men's estimates of prostate cancer risk and self-reported rates of screening. Med J Aust 1997, 167, 250-253.
33. Lisspers J, Nygren A, Söderman E. Hospital Anxiety and Depression Scale (HAD): some psychometric data for a Swedish sample. Ada Psychiatr Scand 1997, 96, 281-286.
34. Spinhoven P, Ormel J, Sloekers P, Kempen G, Speckens A, van Hemert A. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med 1997, 27, 363-370.
35. Kerlikowske K, Grady D, Rubin S, Sandrock C, Ernster V. Efficacy of screening mammography: a meta-analysis. J Am Med Assoc 1995, 273, 149-154.
36. Janis IL, Feshbach S. Fear arousing communications. J Abnorm Soc Psychol 1953, 48, 78-92.